Repare Therapeutics, Inc. (RPTX)
2.58
+0.01
(+0.39%)
USD |
NASDAQ |
Jan 16, 16:00
2.61
+0.03
(+1.16%)
After-Hours: 20:00
Repare Therapeutics EPS Diluted (Quarterly): 0.0757 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 2.434 |
| Achieve Life Sciences, Inc. | -0.2831 |
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.3157 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.258M |
| Revenue (Quarterly) | 11.62M |
| Total Expenses (Quarterly) | 8.362M |
| Enterprise Value | -1.042M |
| Gross Profit Margin (Quarterly) | 99.38% |
| Profit Margin (Quarterly) | 28.04% |
| Earnings Yield | -65.67% |
| Normalized Earnings Yield | -60.39 |